Handelsavisen
prelaunch
Companies Financials CBNK.CM
CB
CBNK.CM Banks

Cbnk.Cm

$8,50
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
Op margin
6,7 %
ROE
4,5 %
Net margin
6,1 %
Debt / equity
6,31
Beta
52w range
Volume
Day range
Prev close
$36,13
Open
Next earnings
2026-10-28
Ex-dividend
TR 1Y
About

CBNK.CM operates in the banking industry, providing financial services including asset management, lending, and deposit-taking, generating revenue primarily through net interest income and fee-based services.

Business. Capital Bancorp Inc (CBNK) is a commercial bank headquartered in the United States, operating within the Banking Services industry group. The company generates revenue primarily through interest income, consistent with standard commercial banking activities. It is listed on the Nasdaq stock exchange under the ticker symbol CBNK. Specific details regarding operating segments or geographic concentrations are not provided.

Classification92 %
SectorFinancials
Business sectorBanking & Investment Services
IndustryBanks
Generated · model-assisted
Sell-side consensus
BUY4 analysts
3 buy1 hold0 sell
Avg 12m price target36,25

Analyst recommendations

4 analysts · consensus Buy
Buy3
Hold1
Sell0
12-month price target
36,25
Consensus of sell-side coverage.
Upcoming events
  • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
Buy
4 analysts · indicative
Ownership
not yet wired
Profitability
4,5 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning CBNK.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials · THIS SECTOR−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to CBNK.CM. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Company
    • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
    • Peers
    • DividendDividend USD 1.75/sh2026-09-25 · Bank of America (BAC)
    • EarningsQ3 2026 earnings (expected)2026-10-13 · estimated · JPMorgan Chase (JPM)
    • EarningsQ3 2026 earnings (expected)2026-10-13 · estimated · Citigroup (C)
    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Capital Bancorp Inc (CBNK) is a commercial bank headquartered in the United States, operating within the Banking Services industry group. The company generates revenue primarily through interest income, consistent with standard commercial banking activities. It is listed on the Nasdaq stock exchange under the ticker symbol CBNK. Specific details regarding operating segments or geographic concentrations are not provided.

    Classification92 %
    SectorFinancials
    Business sectorBanking & Investment Services
    IndustryBanks
    AI synthesis
    GENERATED

    CBNK.CM maintains a liquidity position with a cash and equivalents balance of 4.61 billion LKR, but its liquidity is constrained by a long-term debt of 76.46 billion LKR, resulting in a negative net cash position. The company's liquidity risk is assessed as medium, with a debt-to-equity ratio of 6.31, indicating a high reliance on debt financing.

    Profitability metrics show a return on equity (ROE) of 4.47% and a return on assets (ROA) of 0.59%, both below the typical performance benchmarks for the banking industry. These figures suggest that the company is generating modest returns relative to its equity and asset base.

    The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic fluctuations and regulatory changes. No specific geographic revenue breakdown is available in the provided data.

    Looking ahead, the company is expected to maintain a stable revenue trajectory, with no significant growth or decline projected in the next fiscal year. Historical revenue data indicates a consistent but moderate performance, with no sharp increases or decreases in the most recent period.

    Risk factors include a medium liquidity risk and a low dilution risk. The company has not issued additional shares recently, and there is no indication of near-term dilution pressure. However, the high debt-to-equity ratio suggests potential refinancing risks in the future.

    Recent filings and transcripts do not indicate any major strategic shifts or operational disruptions. The company appears to be maintaining its current business model and financial strategy, with no significant new initiatives disclosed in the latest available documents.

    Key takeaways
    • CBNK.CM has a high debt-to-equity ratio of 6.31, indicating a significant reliance on debt financing.
    • The company's ROE of 4.47% and ROA of 0.59% are below typical industry benchmarks, suggesting modest profitability.
    • CBNK.CM maintains a single business segment with no disclosed geographic diversification, increasing regional risk exposure.
    • The company's liquidity risk is assessed as medium, with a negative net cash position after accounting for long-term debt.
    • No significant dilution pressure is expected in the near term, and the company has not issued additional shares recently.

    Bull / Bear case

    Generated · model-assisted
    BULL CASE · 5

    Capital Bancorp trades at a 1.61 price-to-book multiple, indicating the market values its equity above tangible book value.

    The company maintains a zero debt-to-equity ratio, ranking above the 75th percentile within its banking peer cohort.

    Total assets grew at a 20% compound annual growth rate over the last five years, demonstrating balance sheet expansion.

    Equity expanded with an 18% compound annual growth rate over the past five years, supporting capital base growth.

    Cash conversion metrics rank above the median for the banking cohort, suggesting relatively efficient cash generation capabilities.

    BEAR CASE · 2

    Return on assets of 0.32% indicates extremely poor asset utilization efficiency compared to industry standards for banks.

    Total assets contracted by 11.1% year-over-year in FY2025, reflecting a shrinking balance sheet and potential business decline.

    In focus — financials by report

    Valuation

    Market price
    $8,50
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $12.12B
    Net cash
    -$71.85B
    Current ratio
    Debt / equity
    6.3
    ROA
    0.6%
    ROE
    4.5%
    Cash conversion
    437.0%
    CapEx / revenue
    -2.5%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Low$35,00
    Mean$36,25
    Median$35,00
    High$40,00
    Spot$8,50
    +326.5 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin6,7 %Below median
    Net Margin6,1 %Bottom quartile
    ROE4,5 %Below median
    Capex / Rev-2,5 %Above median
    D/E6,31Bottom quartile
    Cash Conv4,37Best in class

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • CBNK.CM Market data — financials · 2026-05-27

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    653.3Kshares short+1.0% vs prior
    12.05days to cover
    62.3%short of daily vol
    863fails-to-deliver
    as of 2026-07-15 · short-interest report (free)

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    CBNK.CMCanonical
    — · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.
    Relationship graph
    CBNKJPMBACCBanks
    This companyPeerSector

    Evidence & claims

    From filings & derived data
    • Total assets (YoY) (2025-12-31 vs 2024-12-31): 12.5%Derived (calculated)
    • Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): 13.1%Derived (calculated)
    • Total liabilities (YoY) (2025-12-31 vs 2024-12-31): 12.4%Derived (calculated)
    • Return on equity (FY 2025-12-31): 14.2%Derived (calculated)
    • Return on assets (FY 2025-12-31): 1.6%Derived (calculated)
    • Debt-to-equity (FY 2025-12-31): 7.98xDerived (calculated)
    • EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): 62.7%Derived (calculated)
    • EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): 60.8%Derived (calculated)
    • Net income (YoY) (2025-12-31 vs 2024-12-31): 84.6%Derived (calculated)
    • Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): 99.6%Derived (calculated)
    • EPS (basic) (annual): USD-PER-SHARES 3SEC XBRL filing
    • Shares outstanding (annual): 16.37MSEC XBRL filing
    • Shareholders' equity (annual): USD 401.76MSEC XBRL filing
    • Pre-tax income (annual): USD 74.94MSEC XBRL filing
    • Net income (annual): USD 57.17MSEC XBRL filing
    • Total assets (annual): USD 3.61BSEC XBRL filing
    • Total liabilities (annual): USD 3.2BSEC XBRL filing
    • Operating cash flow (annual): USD 69.72MSEC XBRL filing
    • EPS (diluted) (annual): USD-PER-SHARES 3SEC XBRL filing
    • Return on equity (FY 2024-12-31): 8.7%Derived (calculated)
    • EPS (basic) (YoY) (2024-12-31 vs 2023-12-31): -17.2%Derived (calculated)
    • Operating cash flow (YoY) (2024-12-31 vs 2023-12-31): -26.3%Derived (calculated)
    • Total assets (YoY) (2024-12-31 vs 2023-12-31): 44.1%Derived (calculated)
    • Total liabilities (YoY) (2024-12-31 vs 2023-12-31): 44.7%Derived (calculated)
    Showing 24 of 60 surfaced claims.
    Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.

    The Thread

    Everything we know, in order
    2026-10-28EVENTUpcomingQ3 2026 earnings (expected) estimated date
    2026-07-27 00:00 UTCTRANSCRIPTEarnings call — Q3 2026
    2026-07-27EVENTQ2 2026 earnings (expected) estimated date
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage